A detailed history of Northwest & Ethical Investments L.P. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 71,139 shares of BHC stock, worth $438,216. This represents 0.02% of its overall portfolio holdings.

Number of Shares
71,139
Previous 32,384 119.67%
Holding current value
$438,216
Previous $264 Million 117.13%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$7.34 - $9.78 $284,461 - $379,023
38,755 Added 119.67%
71,139 $574 Million
Q3 2024

Nov 13, 2024

BUY
$5.22 - $8.26 $19,491 - $30,842
3,734 Added 13.03%
32,384 $264 Million
Q2 2024

Aug 14, 2024

BUY
$6.1 - $10.41 $174,765 - $298,246
28,650 New
28,650 $200 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.23B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Northwest & Ethical Investments L.P. Portfolio

Follow Northwest & Ethical Investments L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.